Prevalence and predictors of positive tuberculin skin test results in a research laboratory

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 4, 2008, Pages 416-418

  Pilsczek, Florian H ^a,b   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Latent tuberculosis; Prevalence; Research laboratory; Risk factors

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; FEMALE; FOREIGN PROFESSIONAL PERSONNEL; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; LABORATORY PERSONNEL; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 56049089444     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000400019     Document Type: Article

References (18)

1. Cobelens FG, van Deutekom H, Draayer-Jansen IW, Schepp-Beelen AC, van Gerven PJ, van Kessel RP, Mensen ME. Association of tuberculin sensitivity in Dutch adults with history of travel to areas of with a high incidence of tuberculosis. Clinical Infectious Diseases 33: 300-304, 2001.
2. Collins CH. Laboratory-acquired tuberculosis. Tubercle 63: 151-155, 1982.
3. Collins CH, Grange JM. Tuberculosis acquired in laboratories and necropsy rooms. Community Diseases Public Health 2: 161-167, 1999.
4. Daniello J, Zollner I. Experiences with the intracutaneous Mendel-Mantoux tuberculin test in routine screening in a public health office. Gesundheitswesen 59: 519-522, 1997.
5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Journal of the American Medical Association 282: 677-686, 1999.
6. Grist NR, Emslie J. Infections in British clinical laboratories, 1982-3. Journal of Clinical Pathology 38: 721-725, 1985.
7. Grist NR, Emslie JA. Infections in British clinical laboratories, 1986-87. Journal of Clinical Pathology 42: 677-681, 1989.
8. Kao AS, Ashford DA, McNeil MM, Warren NG, Good RC. Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories. Journal of Clinical Microbiology 35: 1847-1851, 1997.
9. Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS, Ewer K, Hill AV, Mehta A, Rodrigues C. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. Journal of Infectious Diseases 183: 469-477, 2001.
10. Maciel EL, Meireles W, Silva AP, Fiorotti K, Dietze R. Nosocomial Mycobacterium tuberculosis transmission among healthcare students in a high incidence region, in Vitória, State of Espírito Santo. Revista da Sociedade Brasileira de Medicina Tropical 40: 397-399, 2007.
11. Maciel EL, Viana MC, Zeitoune RC, Ferreira I, Fregona G, Dietze R. Prevalence and incidence of Mycobacterium tuberculosis infection in nursing students in Vitória, Espírito Santo. Revista da Sociedade Brasileira de Medicina Tropical 38: 469-472, 2005.
12. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Pai M, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. Journal of the American Medical Association 293: 2746-2755, 2005.
13. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Reviews of Molecular of Molecular Diagnosis 6: 413-422, 2006.
14. Peerbooms PG, van Doornum GJ, van Deutekom H, Coutinho RA, van Soolingen D. Laboratory-acquired tuberculosis. Lancet 345: 1311-1312, 1995.
15. Roncarati E, De Bartolomeo A, Atti G. Tuberculin survey and its meaning for a correct prevention in a high risk population. Epidemiological data relative to students of the faculty of medicine and soldiers residing in Ferrara (author's transl). Annals Sclavocia 22: 982-992, 1980.
16. Syed Q, Bellis MA, Beeching NJ, Tocque K, Williams CS, Jamieson J, Steele A, Davies PD. Tuberculin testing in two Liverpool social clubs: the effects of a tuberculosis outbreak on background positivity. Thorax 51: 624-627, 1996.
17. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Journal of Respiratory and Critical Care Medicine 161: S221-S247, 2000.
18. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infectious Diseases 3: 578-590, 2003.